Evidence map›Paper›PMID 30745939›Full record

ArticleAnnals of thoracic medicine

Immunization status in chronic obstructive pulmonary disease: A multicenter study from Turkey.

Tevfik Ozlu, Yilmaz Bulbul, Derya Aydin, Dursun Tatar, Tulin Kuyucu, Fatma Erboy, Handan Inonu Koseoglu, Ceyda Anar, Aysel Sunnetcioglu, Pinar Yildiz Gulhan and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of thoracic medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 1 country.

Tevfik OzluDepartment of Chest Diseases, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Yilmaz BulbulDepartment of Chest Diseases, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Derya AydinChest Disease Clinic, Pulmonary Diseases Hospital, Balikesir, Turkey.
Dursun TatarDepartment of Pulmonary Diseases, Dr. Suat Seren Pulmonary Diseases and Thoracic Surgery Education and Research Hospital, Izmir, Turkey.
Tulin KuyucuDepartment of Pulmonary Diseases, Sureyyapasa Pulmonary Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey.
Fatma ErboyDepartment of Chest Diseases, School of Medicine, Bulent Ecevit University, Zonguldak, Turkey.
Handan Inonu KoseogluDepartment of Chest Diseases, School of Medicine, Gaziosmanpasa University, Tokat, Turkey.
Ceyda AnarDepartment of Pulmonary Diseases, Dr. Suat Seren Pulmonary Diseases and Thoracic Surgery Education and Research Hospital, Izmir, Turkey.
Aysel SunnetciogluDepartment of Chest Diseases, School of Medicine, Yuzuncu Yil University, Van, Turkey.
Pinar Yildiz GulhanChest Disease Clinic, Tosya State Hospital, Kastamonu, Turkey.
Unal SahinDepartment of Chest Diseases, School of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.
Aydanur EkiciDepartment of Chest Diseases, School of Medicine, Kırıkkale University, Kırıkkale, Turkey.
Serap DuruDepartment of Pulmonary Diseases, Diskapi Yildirim Beyazid Education and Research Hospital, Ankara, Turkey.
Sevinc Sarinc UlasliDepartment of Chest Diseases, School of Medicine, Hacettepe University, Ankara, Turkey.
Ercan KurtipekDepartment of Pulmonary Diseases, Konya Education and Research Hospital, Konya, Turkey.
Sibel GunayChest Disease Clinic, Afyon State Hospital, Afyon, Turkey.
RIMPACT Study Investigators
Karadeniz Technical University · TRAfyon Kocatepe University · TRBülent Ecevit University · TRDışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi · TRHacettepe University · TRKırıkkale University · TRKonya Eğitim ve Araştırma Hastanesi · TRRecep Tayyip Erdoğan University · TRTokat Gaziosmanpaşa Üniversitesi · TRVan Yüzüncü Yıl Üniversitesi · TRYedikule Teaching Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this study is to detect the prevalence and the factors associated with influenza and pneumococcal vaccination and outcomes of vaccination during 2013-2014 season in patients with chronic obstructive pulmonary disease (COPD) in Turkey.

methodsThis was a multicenter retrospective cohort study performed in 53 different centers in Turkey.

resultsDuring the study period, 4968 patients were included. COPD was staged as GOLD 1-2-3-4 in 9.0%, 42.8%, 35.0%, and 13.2% of the patients, respectively. Influenza vaccination rate in the previous year was 37.9%; and pneumococcus vaccination rate, at least once during in a life time, was 13.3%. Patients with older age, higher level of education, more severe COPD, and comorbidities, ex-smokers, and patients residing in urban areas had higher rates of influenza vaccination. Multivariate logistic regression analysis showed that advanced age, higher education levels, presence of comorbidities, higher COPD stages, and exacerbation rates were associated with both influenza and pneumococcal vaccination. The number of annual physician/outpatient visits and hospitalizations due to COPD exacerbation was 2.73 ± 2.85 and 0.92 ± 1.58 per year, respectively. Patients with older age, lower education levels, more severe COPD, comorbid diseases, and lower body mass index and patients who are male and are residing in rural areas and vaccinated for influenza had significantly higher rates of COPD exacerbation.

conclusionsThe rates of influenza and pneumococcal vaccination in COPD patients were quite low, and the number of annual physician/outpatient visits and hospitalizations due to COPD exacerbation was high in Turkey. Advanced age, higher education levels, comorbidities, and higher COPD stages were associated with both influenza and pneumococcal vaccination.

Indexed as

Chronic obstructive pulmonary diseasechronic obstructive pulmonary disease exacerbationinfluenza vaccinepneumococcal vaccine

Identifiers

PMID30745939
PMCPMC6341858
OpenAlexW2909811534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.